ARA-290: Non-Erythropoietic Tissue Protection
Research Focus: Derived from erythropoietin, ARA-290 targets the Innate Repair Receptor. It offers potent anti-inflammatory and neuroprotective effects without the cardiovascular risks of increased red blood cell production.
